LSI Epsilon invest in SampleFacts

av | 8 maj, 2025 | LSI Epsilon, Nyheter

So excited to introduce our 8th investment. SampleFacts is reinventing blood 🩸 sampling by separating blood and plasma instantly. We look forward to work closely with Maryam Poorafshar, Kristina Svensson, Frida Ekholm, Ulf Landegren, Jon-Sverre Schanche and rest of...

LSI Epsilon invest in Bioservo

av | 27 februari, 2025 | LSI Epsilon

Glad to introduce our seventh investment Bioservo AB. Bioservo is a world-leading company within wearable grip-strengthening systems. Looking forward to work with Petter Bäckgren, Mikael Wester, Philip Simonson, Annika Rydgård and rest of the team. Listen to Petter...

LSI Epsilon invest in VoxlBio

av | 20 februari, 2025 | LSI Epsilon

We are happy to announce LSI Epsilons sixth investment VoxlBio. VoxlBio are empowering discoveries through advanced genetic spatial analysis. Tools that change how we can understand and diagnose komplex diseases as cancer. We are looking forward to the journey...

LSI Epsilon invest in Videm

av | 15 november, 2024 | LSI Epsilon

We are super happy to present VIDEM, LSI Epsilons fifth investment. Videm provides accurate, accessible and affordable disease diagnostics to improve global health. You will also find Videm on NyTeknik – First with news about technology and IT.s newly published...

LSI Epsilon invest in BrainZell

av | 6 november, 2024 | LSI Epsilon

We are happy to welcome BrainZell to the LSI Epsilon family. By replacing and reducing traditional animal testing with cutting-edge human cell models, BrainZell are shaping a more sustainable future for medicine. We are looking forward to work with Petra Szeszula,...

LSI Epsilon invest in AAX Biotech.

av | 2 oktober, 2024 | LSI Epsilon

Say hi to AAX Biotech AB! ✨ It is with excitement and joy we present LSI Epsilon’s third investment. AAX Biotech is a Swedish biotech company enabling and accelerating the development of highly effective antibody-based medicines. We look forward to work with...